1. Home
  2. YELP vs PGEN Comparison

YELP vs PGEN Comparison

Compare YELP & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$21.85

Market Cap

1.2B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.28

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YELP
PGEN
Founded
2004
1998
Country
United States
United States
Employees
5168
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2011
2013

Fundamental Metrics

Financial Performance
Metric
YELP
PGEN
Price
$21.85
$4.28
Analyst Decision
Hold
Buy
Analyst Count
6
5
Target Price
$29.17
$8.33
AVG Volume (30 Days)
1.2M
3.0M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
19.15
N/A
EPS
0.30
N/A
Revenue
$1,464,955,000.00
$230,981,000.00
Revenue This Year
$2.19
$1,115.92
Revenue Next Year
$2.34
$81.04
P/E Ratio
$74.80
N/A
Revenue Growth
3.75
N/A
52 Week Low
$19.60
$1.28
52 Week High
$39.58
$5.47

Technical Indicators

Market Signals
Indicator
YELP
PGEN
Relative Strength Index (RSI) 32.74 53.93
Support Level $19.60 $3.97
Resistance Level $25.09 $4.40
Average True Range (ATR) 1.34 0.25
MACD -0.57 -0.01
Stochastic Oscillator 12.24 36.41

Price Performance

Historical Comparison
YELP
PGEN

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making appropriate buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States, and also has its presence in other countries.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: